Bronte-Stewart Memorial Lecture: Professor Mark Richards

Bronte-Stewart Memorial Lecture - Professor Mark Richards

Professor in Medicine and Director, Cardiovascular Research Institute, National University of Singapore

"A Peptide's Progress: from biological curiosity to biomarkers with global impact"

Friday 31st August 2018, 2-3pm

Yudowitz Lecture Theatre, Wolfson Medical School Building

Professor Richards was appointed in November 2009 as the Director of Cardiovascular Research Institute (CVRI) and Professor in the Department of Medicine, National University of Singapore (NUS). He holds adjunct appointments with Biochemistry, Yoo Loo Lin School of Medicine and with the Genome Institute of Singapore.

Professor Richards is a New Zealand graduate with specialist qualifications in general cardiology and special interest and experience in endocrine hypertension, heart failure and coronary heart disease. He retains long-standing appointments as a Cardiologist at the Canterbury District Health Board and Professor in Medicine at the University of Otago, Christchurch. He is co-director of the Christchurch Heart Institute and Professor of Cardiovascular Studies for the National Heart Foundation of New Zealand. He works nine months of each year in Singapore and three in Christchurch.

Professor Richards has been actively involved in research and has received numerous local and national research grants from institutions in New Zealand and Singapore. He is author of over 700 peer-reviewed articles (including > 500 original articles) published in cardiovascular, general medicine, hypertension, clinical chemistry and endocrinology journals since 1983. In addition, he is a member of the editorial boards for numerous peer-reviewed journals which include European Journal of Heart Failure, Cardiovascular Drugs Review, JACC:Heart Failure, etc. His major interests have been in the field of neurohormonal control of the heart and circulation in health and disease. Original contributions, over a 33 year research career, include works on multiple neurohormonal factors relevant to control of the circulation and pressure volume homeostasis in health and disease. Areas of expertise include the renin-angiotensin-aldosterone and sympathetic nervous systems and adrenomedullins, urocortins and the natriuretic peptides. His Christchurch group is particularly known for pioneering work in the biology and clinical application of the cardiac natriuretic peptides.

Life time H index = 81 Total Citations > 30,000.